Brought to you by 
Aquapharm closes Series B round
08 Apr 2010
Executive Summary
Aquapharm Biodiscovery Ltd. (developing products derived from marine microbiology) has completed its Series B financing, raising £4.2mm ($6.3mm) from returning shareholders Aescap Venture, Tate & Lyle Ventures, Highlands & Islands Enterprise, and NESTA. The company got the initial £4mm in July 2007 from the same investors as well as Scottish Enterprise.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Aquapharm closes Series B round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice